Jeffery Kelly Net Worth

The estimated Net Worth of Jeffery W. Kelly is at least $964 Тысяча dollars as of 18 December 2017. Jeffery Kelly owns over 4,000 units of Proteostasis Therapeutics Inc stock worth over $963,974 and over the last 9 years he sold PTI stock worth over $0. In addition, he makes $0 as Independent Director at Proteostasis Therapeutics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jeffery Kelly PTI stock SEC Form 4 insiders trading

Jeffery has made over 1 trades of the Proteostasis Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of PTI stock worth $20,000 on 18 December 2017.

The largest trade he's ever made was buying 4,000 units of Proteostasis Therapeutics Inc stock on 18 December 2017 worth over $20,000. On average, Jeffery trades about 667 units every 0 days since 2016. As of 18 December 2017 he still owns at least 102,411 units of Proteostasis Therapeutics Inc stock.

You can see the complete history of Jeffery Kelly stock trades at the bottom of the page.

Jeffery Kelly biography

Dr. Jeffery W. Kelly Ph.D. serves as Independent Director of the Company. Dr. Kelly, a co-founder of our company, has served on our Board of Directors since December 2006, when our company was founded. Since January 2019, he has served on the board of directors and as a scientist of The Scripps Research Institute in La Jolla, California. From September 2008 until 2019, he served as the Chairman of Molecular and Experimental Medicine and the Lita Annenberg Hazen Professor of Chemistry within the Skaggs Institute of Chemical Biology at The Scripps Research Institute. From August 2000 to December 2008, he served as Dean of Graduate Studies at The Scripps Research Institute, and from July 2000 to December 2006, he also served as Vice President of Academic Affairs. Dr. Kelly also co-founded FoldRx Pharmaceuticals, Inc. and Misfolding Diagnostics Inc. He received his Ph.D. in organic chemistry from the University of North Carolina at Chapel Hill.

How old is Jeffery Kelly?

Jeffery Kelly is 59, he's been the Independent Director of Proteostasis Therapeutics Inc since 2006. There are 2 older and 7 younger executives at Proteostasis Therapeutics Inc. The oldest executive at Proteostasis Therapeutics Inc is Franklin Berger, 70, who is the Independent Chairman of the Board.

What's Jeffery Kelly's mailing address?

Jeffery's mailing address filed with the SEC is C/O PROTEOSTASIS THERAPEUTICS, INC., 80 GUEST STREET, 5TH FLOOR, BOSTON, MA, 02135.

Insiders trading at Proteostasis Therapeutics Inc

Over the last 9 years, insiders at Proteostasis Therapeutics Inc have traded over $9,140,918 worth of Proteostasis Therapeutics Inc stock and bought 12,301,024 units worth $94,383,855 . The most active insiders traders include M James Barrett, Llc Fmr и Bioventures Ltd Novartis Ag.... On average, Proteostasis Therapeutics Inc executives and independent directors trade stock every 36 days with the average trade being worth of $3,463,082. The most recent stock trade was executed by Enterprise Associates 12, L... on 26 November 2019, trading 1,283,919 units of PTI stock currently worth $3,222,637.

What does Proteostasis Therapeutics Inc do?

Complete history of Jeffery Kelly stock trades at Proteostasis Therapeutics Inc

Proteostasis Therapeutics Inc executives and stock owners

Proteostasis Therapeutics Inc executives and other stock owners filed with the SEC include:

• Meenu Chhabra,
  President, Chief Executive Officer, Director
• Marija Zecevic,
  Chief Operating Officer
• Benito Munoz,
  Chief Scientific Officer
• Jeffery Kelly,
  Independent Director
• Emmanuel Dulac,
  Independent Director
• Kimberlee Drapkin,
  Independent Director
• Badrul Chowdhury,
  Independent Director
• David Arkowitz,
  Independent Director
• Geoffrey Gilmartin,
  Chief Medical Officer
• Franklin Berger,
  Independent Chairman of the Board
• Eric Rabinowitz,
  Director
• Co Plc Perrigo Holdings Ltd...,
  
• M James Barrett,
  Director
• Asset Management, Lp Chen B...,
  
• James M. Detore,
  See Remarks
• Llc Fmr,
  
• Brett R Hagen,
  Principal Accounting Officer
• Po Shun Lee,
  See Remarks
• Bioventures Ltd Novartis Ag...,
  
• Enterprise Associates 12, L...,
  
• Eric D Larson,
  See Remarks
• Helen M Boudreau,
  Director
• Enterprise Associates 12, L...,
  
• Sheila Wilson,
  Chief Operating Officer
• Christopher T Phd Walsh,
  Director
• Janet L Smart,
  See Remarks
• Christopher Mirabelli,
  Director
• Romeo Mirzac,
  Principal Accounting Officer
• Christopher Health Care Ven...,
  
• Conor M Walshe,
  Director